|
US3740421A
(en)
|
1966-09-19 |
1973-06-19 |
Basf Wyandotte Corp |
Polyoxyethylene-polyoxypropylene aqueous gels
|
|
EP0027888B1
(en)
|
1979-09-21 |
1986-04-16 |
Hitachi, Ltd. |
Semiconductor switch
|
|
US4673574A
(en)
|
1981-08-31 |
1987-06-16 |
Anderson Porter W |
Immunogenic conjugates
|
|
US4902506A
(en)
|
1983-07-05 |
1990-02-20 |
The University Of Rochester |
Immunogenic conjugates
|
|
US4709017A
(en)
|
1985-06-07 |
1987-11-24 |
President And Fellows Of Harvard College |
Modified toxic vaccines
|
|
US4950740A
(en)
|
1987-03-17 |
1990-08-21 |
Cetus Corporation |
Recombinant diphtheria vaccines
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
|
CA2006700A1
(en)
|
1989-01-17 |
1990-07-17 |
Antonello Pessi |
Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines
|
|
WO1990014837A1
(en)
|
1989-05-25 |
1990-12-13 |
Chiron Corporation |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
|
AU651949B2
(en)
|
1989-07-14 |
1994-08-11 |
American Cyanamid Company |
Cytokine and hormone carriers for conjugate vaccines
|
|
IT1237764B
(it)
|
1989-11-10 |
1993-06-17 |
Eniricerche Spa |
Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
|
|
SE466259B
(sv)
|
1990-05-31 |
1992-01-20 |
Arne Forsgren |
Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
|
|
ATE128628T1
(de)
|
1990-08-13 |
1995-10-15 |
American Cyanamid Co |
Faser-hemagglutinin von bordetella pertussis als träger für konjugierten impfstoff.
|
|
CA2059692C
(en)
|
1991-01-28 |
2004-11-16 |
Peter J. Kniskern |
Pneumoccoccal polysaccharide conjugate vaccine
|
|
CA2059693C
(en)
|
1991-01-28 |
2003-08-19 |
Peter J. Kniskern |
Polysaccharide antigens from streptococcus pneumoniae
|
|
EP0625910B1
(en)
|
1992-02-11 |
2003-07-23 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Dual carrier immunogenic construct
|
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
|
JP3506431B2
(ja)
|
1992-05-06 |
2004-03-15 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
ジフテリア毒素受容体結合領域
|
|
IL102687A
(en)
|
1992-07-30 |
1997-06-10 |
Yeda Res & Dev |
Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
|
|
DK0616034T3
(da)
|
1993-03-05 |
2005-02-21 |
Wyeth Corp |
Plasmid til fremstilling af CRM-protein og diphtheria toxin
|
|
EP0720485B1
(en)
|
1993-09-22 |
2003-11-19 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Method of activating soluble carbohydrate using novel cyanylating reagents for the production of immunogenic constructs
|
|
US5917017A
(en)
|
1994-06-08 |
1999-06-29 |
President And Fellows Of Harvard College |
Diphtheria toxin vaccines bearing a mutated R domain
|
|
US6455673B1
(en)
|
1994-06-08 |
2002-09-24 |
President And Fellows Of Harvard College |
Multi-mutant diphtheria toxin vaccines
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
DE69628418T2
(de)
|
1995-03-22 |
2004-04-01 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Herstellung von immunogenen konstrukten unter verwendung von löslichen kohlehydraten, die durch organische cyanylierungs-reagenzien aktiviert wurden
|
|
CA2196281A1
(en)
|
1995-06-06 |
1996-12-12 |
James J. Mond |
Dual carrier immunogenic construct
|
|
ATE348887T1
(de)
|
1996-10-31 |
2007-01-15 |
Human Genome Sciences Inc |
Streptococcus pneumoniae antigene und impfstoffe
|
|
KR19980067137A
(ko)
|
1997-01-31 |
1998-10-15 |
박원훈 |
알긴산염 초미세과립구를 이용한 폐렴구균 감연중에 대한 백신
|
|
US6299881B1
(en)
|
1997-03-24 |
2001-10-09 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts
|
|
US6113918A
(en)
|
1997-05-08 |
2000-09-05 |
Ribi Immunochem Research, Inc. |
Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
|
|
GB9713156D0
(en)
|
1997-06-20 |
1997-08-27 |
Microbiological Res Authority |
Vaccines
|
|
US6146902A
(en)
|
1998-12-29 |
2000-11-14 |
Aventis Pasteur, Inc. |
Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
|
|
CA2366152A1
(en)
|
1999-03-19 |
2000-09-28 |
Smithkline Beecham Biologicals S.A. |
Streptococcus pneumoniae vaccine
|
|
WO2000061761A2
(en)
|
1999-04-09 |
2000-10-19 |
Techlab, Inc. |
Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
|
|
GB0007432D0
(en)
|
2000-03-27 |
2000-05-17 |
Microbiological Res Authority |
Proteins for use as carriers in conjugate vaccines
|
|
WO2001098334A2
(en)
|
2000-06-20 |
2001-12-27 |
Shire Biochem Inc. |
Streptococcus antigens
|
|
EP1946769B1
(en)
|
2000-06-29 |
2012-05-30 |
SmithKline Beecham Biologicals S.A. |
Multivalent vaccine composition with reduced dose of Haemophilus influenzae type B
|
|
BR0116756A
(pt)
|
2000-12-28 |
2005-01-04 |
Wyeth Corp |
Proteìna protetora recombinante de streptococcus pneumoniae e uso da mesma
|
|
KR100886095B1
(ko)
|
2001-04-16 |
2009-02-27 |
와이어쓰 홀딩스 코포레이션 |
폴리펩티드 항원을 암호화하는 신규한 스트렙토코쿠스 뉴모니애 개방형 판독 프레임 및 이를 포함하는 조성물
|
|
AU2002309706A1
(en)
|
2001-05-11 |
2002-11-25 |
Aventis Pasteur, Inc. |
Novel meningitis conjugate vaccine
|
|
GB0118249D0
(en)
|
2001-07-26 |
2001-09-19 |
Chiron Spa |
Histidine vaccines
|
|
CN100350972C
(zh)
|
2001-07-26 |
2007-11-28 |
启龙股份公司 |
含有铝佐剂和组氨酸的疫苗
|
|
GB0130215D0
(en)
|
2001-12-18 |
2002-02-06 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
US7262024B2
(en)
|
2001-12-20 |
2007-08-28 |
Id Biomedical Corporation |
Streptococcus antigens
|
|
FR2850106B1
(fr)
|
2003-01-17 |
2005-02-25 |
Aventis Pasteur |
Conjugues obtenus par amination reductrice du polysaccharide capsulaire du pneumocoque de serotype 5
|
|
CN103040732B
(zh)
|
2003-02-10 |
2015-04-01 |
伊兰药品公司 |
免疫球蛋白制剂及其制备方法
|
|
MXPA05009579A
(es)
|
2003-03-13 |
2005-11-17 |
Glaxosmithkline Biolog Sa |
Proceso de purificacion para citolisina bacteriana.
|
|
EP1603950A2
(en)
|
2003-03-17 |
2005-12-14 |
Wyeth Holdings Corporation |
Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
|
|
AU2003901717A0
(en)
|
2003-04-10 |
2003-05-01 |
Western Sydney Area Health Service |
Identification of streptococcus pneumoniae serotypes
|
|
DE102004017696A1
(de)
|
2004-04-10 |
2005-10-27 |
Vorwerk & Co. Interholding Gmbh |
Bodenpflegegerät mit einer rotierbaren Bürste
|
|
WO2005120563A2
(en)
|
2004-06-04 |
2005-12-22 |
Pharmexa Inc. |
Induction of an immune response against streptococcus pneumoniae polysaccharides
|
|
US20080219960A1
(en)
|
2004-12-16 |
2008-09-11 |
Masja Nathalie Nierop Groot |
Novel Efficient Production Process for Capsular Polysaccharides of Pathogenic Grampositive Bacteria by Heterologous Expression and Secretion of Complex Polysaccharides in Non-Pathogenic, Non-Invasive Gram-Positive Bacteria
|
|
PL1866342T3
(pl)
|
2005-04-08 |
2019-04-30 |
Wyeth Llc |
Oddzielanie zanieczyszczeń od polisacharydu Streptococcus pneumoniae przez manipulację pH
|
|
US7955605B2
(en)
|
2005-04-08 |
2011-06-07 |
Wyeth Llc |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
US20070184072A1
(en)
|
2005-04-08 |
2007-08-09 |
Wyeth |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
US7709001B2
(en)
|
2005-04-08 |
2010-05-04 |
Wyeth Llc |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
IL308456A
(en)
|
2005-04-08 |
2024-01-01 |
Wyeth Llc |
A multivalent pneumomuroral protein-polysaccharide conjugate preparation
|
|
US7764278B2
(en)
|
2005-06-30 |
2010-07-27 |
Seiko Epson Corporation |
Integrated circuit device and electronic instrument
|
|
JP5792920B2
(ja)
|
2005-12-22 |
2015-10-14 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
ワクチン
|
|
JP5285431B2
(ja)
|
2005-12-28 |
2013-09-11 |
ザ ユーエイビー リサーチ ファウンデイション |
肺炎球菌血清型
|
|
AU2006336520B2
(en)
|
2005-12-28 |
2011-09-15 |
The Uab Research Foundation |
Pneumococcal serotypes
|
|
TW200806315A
(en)
|
2006-04-26 |
2008-02-01 |
Wyeth Corp |
Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
|
|
US8808707B1
(en)
|
2006-05-08 |
2014-08-19 |
Wyeth Llc |
Pneumococcal dosing regimen
|
|
KR101446238B1
(ko)
|
2006-08-07 |
2014-10-01 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
단백질 매트릭스 백신 및 그의 제조방법 및 백신 투여방법
|
|
CA2665169C
(en)
|
2006-10-10 |
2017-02-21 |
Wyeth |
Purification of streptococcus pneumoniae type 3 polysaccharides
|
|
HUE039169T2
(hu)
|
2007-03-23 |
2018-12-28 |
Wyeth Llc |
Rövidített tisztítási eljárás Streptococcus pneumoniae tok-poliszacharidok elõállítására
|
|
EA200901578A1
(ru)
|
2007-06-26 |
2010-08-30 |
Глаксосмитклайн Байолоджикалс С.А. |
Вакцина, содержащая конъюгаты капсульных полисахаридов streptococcus pneumoniae
|
|
US8540955B2
(en)
|
2007-07-10 |
2013-09-24 |
Wyeth Llc |
Process for producing aluminum phosphate
|
|
WO2010080486A2
(en)
|
2008-12-18 |
2010-07-15 |
Wyeth Llc |
Method for controlling streptococcus pneumoniae serotype 19a polysaccharide molecular weight
|
|
EP2385981B1
(en)
|
2008-12-18 |
2019-09-04 |
Wyeth LLC |
Method for controlling streptococcus pneumoniae polysaccharide molecular weight using carbon
|
|
CN101590224A
(zh)
|
2009-06-30 |
2009-12-02 |
广州精达医学科技有限公司 |
高效14价肺炎球菌结合疫苗
|
|
CA2773690A1
(en)
|
2009-09-09 |
2011-03-17 |
Matrivax Research & Development Corp. |
Protein matrix vaccines of improved immunogenicity
|
|
GB0917647D0
(en)
|
2009-10-08 |
2009-11-25 |
Glaxosmithkline Biolog Sa |
Expression system
|
|
TW201136603A
(en)
|
2010-02-09 |
2011-11-01 |
Merck Sharp & Amp Dohme Corp |
15-valent pneumococcal polysaccharide-protein conjugate vaccine composition
|
|
GB201003922D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
|
GB201003924D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
|
EP3626263A1
(en)
|
2010-06-04 |
2020-03-25 |
Wyeth LLC |
Vaccine formulations
|
|
US20130273098A1
(en)
|
2010-12-10 |
2013-10-17 |
Jeffrey T. Blue |
Novel formulations which mitigate agitation-induced aggregation of immunogenic compositions
|
|
CN102068690A
(zh)
|
2010-12-31 |
2011-05-25 |
北京民海生物科技有限公司 |
多价肺炎球菌荚膜多糖结合疫苗及其制备方法
|
|
GB201103836D0
(en)
|
2011-03-07 |
2011-04-20 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
|
ES2728653T3
(es)
|
2011-05-18 |
2019-10-28 |
Matrivax Inc |
Composiciones vacunales con una matriz proteica que incluye policationes
|
|
KR20140038517A
(ko)
|
2011-06-13 |
2014-03-28 |
머크 샤프 앤드 돔 코포레이션 |
천연 또는 돌연변이 형태의 디프테리아 독소의 정제 방법
|
|
KR102057217B1
(ko)
*
|
2012-06-20 |
2020-01-22 |
에스케이바이오사이언스 주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
|
CN103623401A
(zh)
|
2012-08-23 |
2014-03-12 |
北京科兴中维生物技术有限公司 |
多价肺炎球菌荚膜多糖-蛋白质共轭组合物及其制备方法
|
|
CN103656631B
(zh)
*
|
2012-09-24 |
2015-08-19 |
北京科兴中维生物技术有限公司 |
多价肺炎球菌荚膜多糖-蛋白缀合物组合物及其制备方法
|
|
CN103656632B
(zh)
|
2012-09-24 |
2016-01-13 |
北京科兴中维生物技术有限公司 |
多价肺炎球菌荚膜多糖组合物、其制备方法及应用
|
|
KR20140075196A
(ko)
|
2012-12-11 |
2014-06-19 |
에스케이케미칼주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
|
KR20140075201A
(ko)
|
2012-12-11 |
2014-06-19 |
에스케이케미칼주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
|
RU2672053C2
(ru)
|
2012-12-20 |
2018-11-09 |
Пфайзер Инк. |
Способ гликоконъюгации
|
|
ITMI20130142A1
(it)
|
2013-01-31 |
2014-08-01 |
Biosynth Srl |
Vaccini glicoconiugati comprendenti unita' di base di un costrutto molecolare esprimente epitopi multipli incorporati
|
|
CN104069488A
(zh)
|
2013-03-29 |
2014-10-01 |
北京科兴中维生物技术有限公司 |
多价肺炎球菌荚膜多糖-蛋白质共轭组合物及其制备方法
|
|
FI3583947T3
(fi)
*
|
2014-01-21 |
2023-10-12 |
Pfizer |
Streptococcus pneumoniaen kapselipolysakkaridit ja niiden konjugaatit
|
|
IL312327B2
(en)
*
|
2014-01-21 |
2026-02-01 |
Pfizer |
Immunogenic preparations comprising conjugated capsular saccharide antigens and their uses
|
|
BR112016015835B1
(pt)
|
2014-01-21 |
2023-12-26 |
Pfizer Inc |
Processo de preparação de conjugados compreendendo polissacarídeos capsulares de streptococcus pneumoniae
|
|
PL3244917T3
(pl)
|
2015-01-15 |
2023-07-17 |
Pfizer Inc. |
Kompozycje immunogenne do zastosowania w szczepionkach przeciwko pneumokokom
|
|
KR102143534B1
(ko)
|
2015-05-04 |
2020-08-12 |
화이자 인코포레이티드 |
B군 스트렙토코쿠스 폴리사카라이드-단백질 접합체, 접합체를 생산하는 방법, 접합체를 포함하는 면역원성 조성물, 및 그의 용도
|
|
US10729780B2
(en)
|
2015-06-08 |
2020-08-04 |
Serum Institute Of India Private Ltd. |
Methods for improving the adsorption of polysaccharide-protein conjugates and multivalent vaccine formulation obtained thereof
|
|
RS61440B1
(sr)
|
2015-06-23 |
2021-03-31 |
Biological E Ltd |
Multivalentna pneumokokna konjugatna vakcina
|
|
WO2017011338A1
(en)
|
2015-07-10 |
2017-01-19 |
President And Fellows Of Harvard College |
Sortase-mediated coupling of immunogenic polysaccharide-protein conjugates and their use
|
|
KR20250058066A
(ko)
|
2015-07-21 |
2025-04-29 |
화이자 인코포레이티드 |
접합된 캡슐형 사카라이드 항원을 포함하는 면역원성 조성물, 그를 포함하는 키트 및 그의 용도
|
|
GB201518684D0
(en)
|
2015-10-21 |
2015-12-02 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
IL259404B2
(en)
|
2015-11-17 |
2025-08-01 |
Pfizer |
Media and fermentation methods for producing polysaccharides in bacterial cell culture
|
|
US10786561B2
(en)
|
2015-11-20 |
2020-09-29 |
Pfizer Inc. |
Immunogenic compositions for use in pneumococcal vaccines
|
|
EP3474890B1
(en)
|
2016-06-22 |
2026-05-06 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Pneumococcal polysaccharide-protein conjugate composition
|
|
CN105999254A
(zh)
|
2016-06-27 |
2016-10-12 |
北京智飞绿竹生物制药有限公司 |
含2型和12f血清型的15价肺炎球菌结合物组合疫苗
|
|
WO2018009906A1
(en)
|
2016-07-08 |
2018-01-11 |
President And Fellows Of Harvard College |
Whole cell-protein conjugates and methods of making the same
|
|
CN109845298B
(zh)
|
2016-07-27 |
2021-12-28 |
夏普株式会社 |
使用系统信息值标签的无线电信方法和装置
|
|
EP3493837B1
(en)
|
2016-08-05 |
2022-08-31 |
Sanofi Pasteur, Inc. |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
US11224652B2
(en)
|
2016-08-05 |
2022-01-18 |
Sanofi Pasteur Inc. |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
WO2018048141A1
(ko)
|
2016-09-06 |
2018-03-15 |
주식회사 엘지화학 |
다가 협막 다당류-운반 단백질을 포함하는 조성물 및 이의 용도
|
|
CN109789198B
(zh)
|
2016-09-30 |
2024-08-16 |
生物E有限公司 |
包含多糖-蛋白缀合物的多价肺炎球菌疫苗组合物
|
|
KR20180043122A
(ko)
|
2016-10-19 |
2018-04-27 |
동국대학교 산학협력단 |
신규링커를 통한 폐렴구균 다당류-단백질 접합체 백신 및 이의 용도
|
|
WO2018080213A1
(ko)
|
2016-10-28 |
2018-05-03 |
주식회사 엘지화학 |
향상된 IgG 역가를 갖는 다가면역원성 조성물 및 이의 용도
|
|
CN108144056A
(zh)
|
2016-12-02 |
2018-06-12 |
武汉博沃生物科技有限公司 |
多价肺炎球菌多糖结合疫苗及其制备方法
|
|
BR112019014833A2
(pt)
|
2017-01-20 |
2020-04-14 |
Pfizer |
composições imunogênicas para uso em vacinas pneumococais
|
|
WO2018144439A1
(en)
|
2017-01-31 |
2018-08-09 |
Merck Sharp & Dohme Corp. |
Methods for making polysaccharide-protein conjugates
|
|
CN110225757A
(zh)
|
2017-01-31 |
2019-09-10 |
默沙东公司 |
由肺炎链球菌血清型19f生产荚膜多糖蛋白缀合物的方法
|
|
JP7680185B2
(ja)
|
2017-02-24 |
2025-05-20 |
メルク・シャープ・アンド・ドーム・エルエルシー |
肺炎連鎖球菌多糖-タンパク質コンジュゲートの免疫原性の増強
|
|
US20200061542A1
(en)
|
2017-02-24 |
2020-02-27 |
Merck Sharp & Dohme Corp. |
Methods for improving filterability of polysaccharide-protein conjugate reactions
|
|
CN110392690B
(zh)
|
2017-02-24 |
2024-01-30 |
默沙东有限责任公司 |
肺炎球菌缀合物疫苗制剂
|
|
US11219680B2
(en)
|
2017-02-24 |
2022-01-11 |
Merck Sharp & Dohme Corp. |
Polysaccharide-protein conjugates utilizing diphtheria toxin fragment B as a carrier
|
|
WO2019050818A1
(en)
|
2017-09-07 |
2019-03-14 |
Merck Sharp & Dohme Corp. |
METHODS OF FORMULATING PNEUMOCOCCAL POLYSACCHARIDES FOR CONJUGATION TO A CARRIER PROTEIN
|
|
WO2018169303A1
(ko)
|
2017-03-15 |
2018-09-20 |
주식회사 엘지화학 |
다가 폐렴구균 백신 조성물
|
|
CN107929728A
(zh)
|
2017-04-19 |
2018-04-20 |
武汉博沃生物科技有限公司 |
一种肺炎球菌蛋白疫苗及其制备方法
|
|
MX2019014829A
(es)
|
2017-06-10 |
2020-08-17 |
Inventprise Llc |
Vacunas de conjugado multivalente con polisacáridos de conjugado bivalente o multivalente que proporcionan inmunogenicidad y avidez mejoradas.
|
|
CN109091668A
(zh)
|
2017-06-20 |
2018-12-28 |
浙江博和瑞达生物科技有限公司 |
16价肺炎链球菌结合疫苗组合物
|
|
WO2019036313A1
(en)
|
2017-08-16 |
2019-02-21 |
Merck Sharp & Dohme Corp. |
CONJUGATED PNEUMOCOCCAL VACCINE FORMULATIONS
|
|
HUE068482T2
(hu)
|
2017-09-07 |
2025-01-28 |
Merck Sharp & Dohme Llc |
Pneumococcus-poliszacharidok és azok felhasználása immunogén poliszacharid-hordozóprotein konjugátumokban
|
|
CA3074706A1
(en)
|
2017-09-07 |
2019-03-14 |
Merck Sharp & Dohme Corp. |
Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
|
|
US11395849B2
(en)
|
2017-09-07 |
2022-07-26 |
Merck Sharp & Dohme Llc |
Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
|
|
CN111065387B
(zh)
|
2017-09-07 |
2023-08-25 |
默沙东有限责任公司 |
肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途
|
|
EP3691677A4
(en)
|
2017-10-04 |
2021-07-07 |
Pogona, Llc |
COMPOSITIONS OF SACCHARIDE-POLYPEPTIDE CONJUGATES AND THEIR METHODS OF USE
|
|
WO2019083865A1
(en)
|
2017-10-25 |
2019-05-02 |
Merck Sharp & Dohme Corp. |
VACCINES WITH ADJUVANT
|
|
EP3720483B1
(en)
*
|
2017-12-06 |
2025-11-19 |
Merck Sharp & Dohme LLC |
Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
|
|
JP2019118051A
(ja)
|
2017-12-27 |
2019-07-18 |
株式会社デンソー |
表示処理装置
|
|
CN108159408A
(zh)
|
2017-12-29 |
2018-06-15 |
云南沃森生物技术股份有限公司 |
一种多价肺炎球菌多糖-蛋白结合物组合物及其制备方法和应用
|
|
CN108245674A
(zh)
|
2018-01-18 |
2018-07-06 |
北京智飞绿竹生物制药有限公司 |
一种多价肺炎球菌结合物组合疫苗的处方及其制备方法
|
|
CN108079286B
(zh)
|
2018-01-19 |
2020-07-31 |
云南沃森生物技术股份有限公司 |
一种13价肺炎球菌多糖-蛋白结合物组合物及其制备方法和应用
|
|
WO2019152921A1
(en)
|
2018-02-05 |
2019-08-08 |
Sanofi Pasteur Inc. |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
BR112020015696A2
(pt)
|
2018-02-05 |
2020-12-08 |
Sanofi Pasteur, Inc. |
Composição de conjugado polissacarídeo-proteína pneumocócico multivalente
|
|
WO2019170068A1
(zh)
|
2018-03-05 |
2019-09-12 |
武汉博沃生物科技有限公司 |
一种肺炎链球菌疫苗及其制备方法
|
|
TW202011985A
(zh)
|
2018-04-18 |
2020-04-01 |
韓商Sk生物科學股份有限公司 |
肺炎鏈球菌的莢膜多醣類以及其免疫原性接合體
|
|
JP7397000B2
(ja)
|
2018-04-30 |
2023-12-12 |
メルク・シャープ・アンド・ドーム・エルエルシー |
凍結乾燥変異ジフテリア毒素のジメチルスルホキシド中均一溶液を提供する方法
|
|
WO2019212842A1
(en)
|
2018-04-30 |
2019-11-07 |
Merck Sharp & Dohme Corp. |
Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates from lyospheres
|
|
WO2019212846A1
(en)
|
2018-04-30 |
2019-11-07 |
Merck Sharp & Dohme Corp. |
Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates
|
|
US20210236384A1
(en)
|
2018-05-07 |
2021-08-05 |
Meissner Filtration Products |
Lyophilization Bag
|
|
CN108339115B
(zh)
|
2018-05-11 |
2020-07-10 |
武汉博沃生物科技有限公司 |
使用重组载体蛋白的肺炎球菌联合疫苗及其制备方法
|
|
WO2019220304A1
(en)
|
2018-05-14 |
2019-11-21 |
Tergene Biotech Pvt. Ltd. |
15 valent pneumococcal polysaccharide conjugate vaccine
|
|
EP3801469A4
(en)
|
2018-06-07 |
2022-03-09 |
Merck Sharp & Dohme Corp. |
CRITICAL LYOSPHERE REAGENTS KIT
|
|
CN108524926B
(zh)
|
2018-06-29 |
2021-06-29 |
康希诺生物股份公司 |
一种多价肺炎球菌结合疫苗的制剂组合及其应用
|
|
WO2020009462A1
(ko)
|
2018-07-06 |
2020-01-09 |
주식회사 유바이오로직스 |
다가 폐렴구균 다당체-단백질 접합체를 포함하는 면역원성 조성물, 및 이를 포함하는 폐렴구균에 의한 질환 예방 백신
|
|
CN108543066A
(zh)
|
2018-07-17 |
2018-09-18 |
成都安特金生物技术有限公司 |
一种24价肺炎球菌多糖疫苗及其鉴别方法
|
|
EA202190318A1
(ru)
|
2018-07-21 |
2021-04-29 |
Байолоджикал И Лимитед |
Составы вакцин, содержащие систему консервантов
|
|
MX2021003358A
(es)
|
2018-09-23 |
2021-05-27 |
Biological E Ltd |
Polisacaridos capsulares purificados de streptococcus pneumoniae.
|
|
CA3120926A1
(en)
|
2018-10-12 |
2020-04-16 |
Biological E Limited |
Multivalent pneumococcal polysaccharide-protein conjugate vaccine
|
|
CN109336989B
(zh)
|
2018-10-22 |
2022-05-13 |
北京智飞绿竹生物制药有限公司 |
一种通过粘度控制制备肺炎球菌荚膜多糖的方法
|
|
US20220016229A1
(en)
|
2018-12-12 |
2022-01-20 |
Pfizer Inc. |
Immunogenic Multiple Hetero-Antigen Polysaccharide-Protein Conjugates and uses thereof
|
|
EP3897705A2
(en)
|
2018-12-19 |
2021-10-27 |
Merck Sharp & Dohme Corp. |
Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
|
|
WO2020152706A1
(en)
|
2019-01-21 |
2020-07-30 |
Biological E Limited |
Multivalent pneumococcal conjugate vaccine compositions
|
|
WO2020157772A1
(en)
|
2019-01-28 |
2020-08-06 |
Biological E Limited |
Multivalent pneumococcal polysaccharide-protein conjugate vaccine compositions
|
|
CN109771640A
(zh)
|
2019-02-28 |
2019-05-21 |
北京智飞绿竹生物制药有限公司 |
多价肺炎球菌结合疫苗
|
|
US20220184199A1
(en)
|
2019-04-10 |
2022-06-16 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
|
|
CA3142692A1
(en)
|
2019-06-05 |
2020-12-10 |
Merck Sharp & Dohme Corp. |
An immunogenic serotype 35b pneumococcal polysaccharide-protein conjugate and conjugation process for making the same
|
|
MX2021014948A
(es)
|
2019-06-05 |
2022-01-24 |
Merck Sharp & Dohme Llc |
Metodos de tratamiento de pacientes con una composicion inmunogenica que protege contra el seroripo 29 de s. pneumoniae.
|
|
CN110302375A
(zh)
|
2019-06-27 |
2019-10-08 |
康希诺生物股份公司 |
一种糖缀合物及其用途
|
|
CN110365663A
(zh)
*
|
2019-06-28 |
2019-10-22 |
北京淇瑀信息科技有限公司 |
一种隔离集群之间的访问方法、装置及电子设备
|
|
KR20210010412A
(ko)
|
2019-07-18 |
2021-01-27 |
(주)셀트리온 |
다가 폐렴구균 다당류-단백질 접합체를 포함하는 면역원성 조성물
|
|
JP2022542316A
(ja)
|
2019-07-31 |
2022-09-30 |
サノフィ パスツール インコーポレイテッド |
多価肺炎球菌多糖体-タンパク質コンジュゲート組成物およびその使用方法
|
|
CN111821432B
(zh)
|
2020-08-05 |
2022-10-18 |
北京智飞绿竹生物制药有限公司 |
一种多价肺炎球菌结合疫苗
|